CLTC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.608400E-01
Normal-vs-Stage2
8.910200E-01
Normal-vs-Stage3
1.328800E-01
Normal-vs-Stage4
4.496200E-01
Stage1-vs-Stage2
7.987000E-01
Stage1-vs-Stage3
1.210780E-01
Stage1-vs-Stage4
3.590400E-01
Stage2-vs-Stage3
1.029440E-01
Stage2-vs-Stage4
4.939000E-01
Stage3-vs-Stage4
2.831700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.256800E-01
Normal-vs-AfricanAmerican
4.365200E-01
Normal-vs-Asian
7.452000E-01
Caucasian-vs-AfricanAmerican
2.056600E-01
Caucasian-vs-Asian
4.647600E-01
AfricanAmerican-vs-Asian
1.261420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.613200E-01
Normal-vs-Female
9.054600E-01
Male-vs-Female
7.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.451400E-01
Normal-vs-Age(41-60Yrs)
4.390600E-01
Normal-vs-Age(61-80Yrs)
9.207200E-01
Normal-vs-Age(81-100Yrs)
5.604600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.521400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.841200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.290000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.141400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.176200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.101600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.956800E-01
Normal-vs-Daily Drinker
2.979800E-01
Normal-vs-Weekly Drinker
8.698200E-01
Normal-vs-Occasional Drinker
5.146600E-01
Normal-vs-Social Drinker
5.118600E-01
Non Drinker-vs-Daily Drinker
5.195600E-01
Non Drinker-vs-Weekly Drinker
3.734400E-01
Non Drinker-vs-Occasional Drinker
2.397500E-02
Non Drinker-vs-Social Drinker
2.826100E-02
Daily Drinker-vs-Weekly Drinker
1.632970E-01
Daily Drinker-vs-Occasional Drinker
1.093950E-02
Daily Drinker-vs-Social Drinker
1.251600E-02
Weekly Drinker-vs-Occasional Drinker
1.394630E-01
Weekly Drinker-vs-Social Drinker
1.501840E-01
Occasional Drinker-vs-Social Drinker
8.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.636840E-01
Normal-vs-Grade 2
1.094250E-01
Normal-vs-Grade 3
8.222200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.875600E-01
Grade 1-vs-Grade 3
3.686800E-01
Grade 1-vs-Grade 4
1.636840E-01
Grade 2-vs-Grade 3
7.837700E-02
Grade 2-vs-Grade 4
1.094250E-01
Grade 3-vs-Grade 4
8.222200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.204200E-01
Normal-vs-NonDiabetic
9.363400E-01
Diabetic-vs-NonDiabetic
3.325600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.741800E-01
Normal-vs-NoPancreatitis
9.575000E-01
Pancreatitis-vs-NoPancreatitis
7.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.300800E-01
Normal-vs-N1
8.980400E-01
N0-vs-N1
7.315400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.611600E-01
Normal-vs-TP53-NonMutant
8.468600E-01
TP53-Mutant-vs-TP53-NonMutant
6.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
